Hepatobiliary disease in the COVID-19 era

Authors

DOI:

https://doi.org/10.52784/27112330.153

Keywords:

COVID-19, hepatobiliary diseases, SARS-CoV-2.

Abstract

The SARS-CoV-2 virus infection has changed for everyone and especially for we, the health personnel, the face of the world that we knew until then. All this has prompted us doctors from the different specialties to work articulated manner and share information at breakneck speed. Commitment of the different organs has forced to care for patients in a multidisciplinary way, and to collaborate with each other to understand the clinical, biochemical and imaging of the new and different syndromes.

Downloads

Download data is not yet available.

Author Biography

Juan Carlos Restrepo-Gutiérrez, Universidad de Antioquia, Hospital Pablo Tobón Uribe

Médico, Especialista en Medicina Interna, Especialista en Hepatología Clínica, MSc, PhD. Profesor Titular, Facultad de Medicina, Universidad de Antioquia. Jefe Sección Gastrohepatología, Coordinador Especialización en Hepatología Clínica, Grupo Gastrohepatología, Universidad de Antioquia. Coordinador Unidad de Hepatología y Programa de Trasplante de Hígado, Hospital Pablo Tobón Uribe, Universidad de Antioquia. Medellín, Colombia.

Downloads

Published

2022-07-05

How to Cite

Restrepo-Gutiérrez, J. C. (2022). Hepatobiliary disease in the COVID-19 era. Hepatología, 3(2), 129–130. https://doi.org/10.52784/27112330.153

Issue

Vol. 3 No. 2 (2022): July-December

Section

Editorial

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Hepatología’s authorship policy is based on the criteria established by the International Committee of Medical Journal Editors (ICMJE) to credit a person for their work while assigning them responsibility for its publication.

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo
Escanea para compartir
QR Code